Snake bites
Etiology & Differentiation :
Pit Vipers (Crotalinae: rattlesnakes, copperheads, cottonmouths) : 1–2 puncture fang marks , rapid local tissue edema/necrosis, hemorrhagic bullae , and consumptive coagulopathy.
Coral Snakes (Elapidae: “red on yellow, kill a fellow”) : Minimal local findings; causes delayed (up to 12h) descending paralysis (ptosis, diplopia, dysarthria) and respiratory arrest .
Contraindicated Interventions (High-Yield) :
DO NOT use tourniquets, arterial bands, ice/cryotherapy, incisions, or suction devices (worsens local tissue ischemia without removing venom). c
DO : Immobilize limb in a neutral position at heart level and transport immediately.
Diagnostic Workup & Monitoring :
Serial exams: Mark advancing edge of erythema/edema and measure limb circumference q15–30 min .
Serial labs (baseline and q2–4h ): ↓ Fibrinogen (earliest/most sensitive marker), ↑ PT/INR , thrombocytopenia , and CK/Cr.
Acute Management :
Initial : ABCs, aggressive IVF resuscitation for shock, and tetanus toxoid update .
Antibiotics : NO prophylactic Abx indicated (wound infections are rare).
Pit Viper Antivenom (CroFab / Anavip) : c
Indications: Rapidly advancing swelling (crosses a major joint), systemic signs (shock), or coagulopathy (platelets < 100k, fibrinogen < 100 mg/dL).
Coral Snake Antivenom :
Administer immediately if bite is confirmed , even if asymptomatic (neurotoxicity is irreversible once symptoms develop).
Surgical Decision-Making :
Suspected Compartment Syndrome : Most cases represent venom-induced subcutaneous edema; give additional antivenom first .
Fasciotomy : Indicated ONLY if intracompartmental pressure > 30 mmHg refractory to antivenom and correction of coagulopathy.
Disposition & Complications :
Observation : Minimum 8–12h for asymptomatic “dry” pit viper bites; 24h in ICU for coral snake bites.
Venom-Induced Consumptive Coagulopathy (VICC) : Severe bleeding risk secondary to defibrination and thrombocytopenia.
Serum Sickness : Type III hypersensitivity reaction occurring 1–2 weeks post-antivenom (fever, urticaria, polyarthralgias); treat with oral corticosteroids .
Hymenoptera stings
Clinical Presentations :
Local Reaction : Minor erythema, edema (< 5 cm), sharp pain; resolves in hours.
Large Local Reaction (LLR) : IgE-mediated contiguous swelling (> 10 cm) peaking at 24–48h; sterile inflammation often confused with cellulitis. c
Systemic (Anaphylaxis) : Urticaria , angioedema , stridor/wheezing , GI cramps, hypotension/shock .
Toxic Envenomation (> 50–100 stings) : Direct toxin load causing rhabdomyolysis , hemolysis, and ATN/AKI .
Diagnosis :
Acute : Purely clinical diagnosis ; obtain serum tryptase only if diagnosis is ambiguous.
Post-Acute Workup : Venom-specific skin testing or venom-specific serum IgE .
Must be delayed ≥ 4–6 weeks post-sting to avoid false negatives (refractory anergic period).
Indicated only for patients with prior systemic/anaphylactic reactions (not for isolated local/LLRs).
Differential Highlights :
Cellulitis : Indolent onset (> 48–72h), fever, purulence, ascending lymphangitis (LLR is sterile and peaks early). c
Brown Recluse Spider : Necrotic ulcer with central violaceous blanching (“bull’s-eye” lesion ).
Black Widow Spider : Dual puncture marks, severe muscle spasms, rigid “board-like” abdomen .
Acute Management :
1st-Line (Life-Saving) : IM Epinephrine (1:1000) in the anterolateral thigh (0.3–0.5 mg in adults; 0.01 mg/kg in kids); repeat q5–15min PRN.
Airway/Breathing : High-flow O2, early endotracheal intubation if stridor/hoarseness develops, inhaled albuterol for bronchospasm.
Circulation : Aggressive IVF boluses (1–2 L isotonic crystalloid) for hypotension; place patient supine/elevate legs.
Adjuncts (Never delay Epinephrine) : IV H1/H2-blockers, systemic corticosteroids (reduce biphasic risk).
Refractory/Special Case : IV Glucagon for patients on beta-blockers with refractory hypotension.
Local/LLR Care : Scrape stinger, cold compresses, oral NSAIDs/antihistamines; short-course PO prednisone for severe LLR (no routine antibiotics).
Disposition & Long-Term Prevention :
Observation : Monitor in ED for 4–8 hours to rule out biphasic reactions .
Discharge : Prescribe two Epinephrine auto-injectors (EpiPens) and provide administration training.
Venom Immunotherapy (VIT) :
Indicated for systemic anaphylaxis + positive skin/IgE test.
Reduces recurrent anaphylaxis risk from 30–60% down to < 5% .
Not indicated for isolated cutaneous reactions in children < 16 years or isolated LLRs.